De Novo SCLC Transformation From KRAS G12C- Mutated Lung Adenocarcinoma With Excellent Response to Sotorasib: A Case Report
JTO CLINICAL AND RESEARCH REPORTS(2023)
摘要
The transformation to SCLC is a known mechanism of resistance against molecularly targeted therapies. This study reports a patient with untreated lung adenocarcinoma, characterized by a KRAS G12C mutation, which transformed into SCLC before treatment. Both the adeno-carcinoma and SCLC components were responsive to sotorasib.(c) 2023 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
更多查看译文
关键词
KRAS G12C,Transformation,Small cell lung cancer (SCLC),Sotorasib,Case report
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要